Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
Frontiers in Pharmacology|February 21, 2017
<i>In vivo</i> Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's DiseaseGeorgia Watt, Tim Karl
Peptides|January 2, 2007
Behavioral profiling of NPY in aggression and neuropsychiatric diseasesTim Karl, Herbert Herzog
Pharmacology, Biochemistry, and Behavior|October 31, 2020
Cannabidiol (CBD) reduces cocaine-environment memory in miceRose Chesworth, Tim Karl
ACS Chemical Neuroscience|January 29, 2019
Dark Classics in Chemical Neuroscience: Δ<sup>9</sup>-TetrahydrocannabinolSamuel D Banister, Jonathon C Arnold, Mark Connor, et al.
Plos One|July 30, 2013
Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profileWendy Swift, Alex Wong, Kong M Li, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2012
Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamineJarrah R Spencer, Keturah M E Darbyshire, Aurelie A Boucher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentCarla Lucia Wahlich, Tim Karl
Scientific Reports|July 23, 2021
Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrationsLyndsey L Anderson, Maia G Etchart, Dilara Bahceci, et al.
Frontiers in Physiology|March 9, 2023
Beyond CBD: Inhibitory effects of lesser studied phytocannabinoids on human voltage-gated sodium channelsCarol J Milligan, Lyndsey L Anderson, Iain S McGregor, et al.
Pageof 21